ArticleWorld journal of surgical oncology2022
The prognostic role of tumor size in stage T1 gastric cancer.
Article in World journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- High Prevalence of Clinical Understaging in Early Gastric Cancer: An Analysis of the NCDB.Annals of surgical oncology · 2026Article
- Prognostic factors for overall survival in patients with early gastric cancer: a retrospective cohort study based on SEER database.Journal of gastrointestinal oncology · 2025Article
- Development of a prognostic nomogram and risk factor analysis for survival inTranslational cancer research · 2025Article
- The value of the radiological diameter-to-thickness ratio in patients with HER2-positive resectable advanced gastric cancer: implications for long survival and stage migration.Abdominal radiology (New York) · 2024Article
- Development and validation of a nomogram to predict cancer-specific survival of elderly patients with unresected gastric cancer who received chemotherapy.Scientific reports · 2024Article
- Article
- The 'double‑track sign': A novel CT finding suggestive of the diagnosis of T1a gastric cancer.Oncology letters · 2023Article
- Tumor size as a significant prognostic factor in T1 gastric cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.BMC gastroenterology · 2023Article
- Clinical significance of the largest histopathological metastatic lymph node size for postoperative course of patients undergoing surgery for gastric cancer.Frontiers in surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose was to assess the contribution of tumor size to the prognosis of patients with gastric cancer.
methodsPatient data were sourced from the Surveillance, Epidemiology, and End Results program (SEER) database. Cox proportional risk regression was performed to determine the prognostic role of tumor size. Kaplan-Meier curves were conducted to calculate survival curves. Consistency index (c-index) and subject exercise curve (ROC) were utilized to assess the predictive ability of each factor on the prognosis of gastric cancer.
resultsTumor size is preferable to other widely accepted prognostic clinical features in forecasting the survival of patients with gastric cancer.
conclusionsThe discriminatory ability of tumor size at T1 stage is superior to many other clinical prognostic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.